Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.9 CHF | +0.86% | -2.38% | +16.01% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.01% | 533M | |
+4.09% | 43.84B | |
+46.23% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea Pharmaceutica : Derazantinib Shows Further Improvement In Bile Duct Cancer Patients